id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
work_dhnjfo4mivfbpgxouhbn2kzl3a	Kai-Jye Lou	Translational tidbits	2014	4	.pdf	application/pdf	3156	376	24	Serono unit and the team at the Institute of Cancer Research (ICR) will research collaboration with Case Western Reserve University to test http://www.biocentury.com/targets/poly(adp-ribose)_polymerase?utm_source=nature http://www.biocentury.com/targets/parp?utm_source=nature http://www.biocentury.com/products/plx_cells?utm_source=nature http://www.biocentury.com/targets/k-ras?utm_source=nature http://www.biocentury.com/targets/kras?utm_source=nature Johnson (NYSE:JNJ) and The ALS Association, with each announcing a quartet of new collaborations or consortia. 200 GPCRs to aid drug development, and the Merck Serono unit of Merck KGaA (Xetra:MRK) partnered with The Institute for Cancer Research Infectious disease $10 million Partnership to develop new vaccine adjuvants China Pharmaceutical University Cancer Unavailable Partnership to investigate an antibody-drug http://www.biocentury.com/targets/tankyrase_trf1-interacting_ankyrin-related_adp-ribose_polymerase?utm_source=nature http://www.biocentury.com/targets/tankyrase_trf1-interacting_ankyrin-related_adp-ribose_polymerase?utm_source=nature http://www.biocentury.com/targets/tankyrase_trf1-interacting_ankyrin-related_adp-ribose_polymerase?utm_source=nature http://www.biocentury.com/targets/tnks2?utm_source=nature http://www.biocentury.com/targets/tnks2?utm_source=nature http://www.biocentury.com/targets/tnks2?utm_source=nature http://www.biocentury.com/targets/tnks2?utm_source=nature http://www.biocentury.com/companies/general_electric_co?utm_source=nature http://www.biocentury.com/companies/xagenic_inc?utm_source=nature http://www.biocentury.com/companies/kineta_inc?utm_source=nature http://www.biocentury.com/companies/biogen_idec_inc?utm_source=nature http://www.biocentury.com/companies/isis_pharmaceuticals_inc?utm_source=nature http://www.biocentury.com/companies/isis_pharmaceuticals_inc?utm_source=nature http://www.biocentury.com/companies/astrazeneca_plc?utm_source=nature http://www.biocentury.com/targets/gpr81?utm_source=nature http://www.biocentury.com/companies/proximagen_group_plc?utm_source=nature http://www.biocentury.com/companies/ubiquigent_ltd?utm_source=nature Columbia University Medical Center, New York, N.Y. Dana-Farber Cancer Institute, Boston, Mass. http://www.biocentury.com/companies/amgen_inc?utm_source=nature http://www.biocentury.com/companies/amgen_inc?utm_source=nature http://www.biocentury.com/companies/amgen_inc?utm_source=nature http://www.biocentury.com/companies/astellas_pharma_inc?utm_source=nature http://www.biocentury.com/companies/astellas_pharma_inc?utm_source=nature http://www.biocentury.com/companies/astellas_pharma_inc?utm_source=nature http://www.biocentury.com/companies/astellas_pharma_inc?utm_source=nature http://www.biocentury.com/companies/genentech_inc?utm_source=nature http://www.biocentury.com/companies/genentech_inc?utm_source=nature http://www.biocentury.com/companies/johnson_and_johnson?utm_source=nature http://www.biocentury.com/companies/johnson_and_johnson?utm_source=nature http://www.biocentury.com/companies/johnson_and_johnson?utm_source=nature http://www.biocentury.com/companies/johnson_and_johnson?utm_source=nature http://www.biocentury.com/companies/merck_kgaa?utm_source=nature http://www.biocentury.com/companies/merck_kgaa?utm_source=nature http://www.biocentury.com/companies/merck_kgaa?utm_source=nature http://www.biocentury.com/companies/novartis_ag?utm_source=nature http://www.biocentury.com/companies/novartis_ag?utm_source=nature http://www.biocentury.com/companies/ono_pharmaceutical_co_ltd?utm_source=nature http://www.biocentury.com/companies/ono_pharmaceutical_co_ltd?utm_source=nature http://www.biocentury.com/companies/ono_pharmaceutical_co_ltd?utm_source=nature http://www.biocentury.com/companies/ono_pharmaceutical_co_ltd?utm_source=nature http://www.biocentury.com/companies/pluristem_therapeutics_inc?utm_source=nature http://www.biocentury.com/companies/pluristem_therapeutics_inc?utm_source=nature http://www.biocentury.com/companies/pluristem_therapeutics_inc?utm_source=nature http://www.biocentury.com/companies/pluristem_therapeutics_inc?utm_source=nature http://www.biocentury.com/companies/regeneron_pharmaceuticals_inc?utm_source=nature http://www.biocentury.com/companies/regeneron_pharmaceuticals_inc?utm_source=nature http://www.biocentury.com/companies/regeneron_pharmaceuticals_inc?utm_source=nature http://www.biocentury.com/companies/regeneron_pharmaceuticals_inc?utm_source=nature http://www.biocentury.com/companies/regeneron_pharmaceuticals_inc?utm_source=nature http://www.biocentury.com/companies/roche?utm_source=nature http://www.biocentury.com/companies/roche?utm_source=nature http://www.biocentury.com/companies/sanofi?utm_source=nature http://www.biocentury.com/companies/sanofi?utm_source=nature http://www.biocentury.com/companies/sanofi?utm_source=nature http://www.biocentury.com/companies/suzhou_industrial_park_biotech_development_co_ltd?utm_source=nature http://www.biocentury.com/companies/suzhou_industrial_park_biotech_development_co_ltd?utm_source=nature http://www.biocentury.com/companies/suzhou_industrial_park_biotech_development_co_ltd?utm_source=nature	./cache/work_dhnjfo4mivfbpgxouhbn2kzl3a.pdf	./txt/work_dhnjfo4mivfbpgxouhbn2kzl3a.txt